(0.26%) 5 113.17 points
(0.22%) 38 325 points
(0.26%) 15 970 points
(-1.31%) $82.75
(3.48%) $1.990
(0.12%) $2 349.90
(0.04%) $27.55
(3.20%) $951.65
(-0.06%) $0.934
(-0.05%) $11.02
(-0.30%) $0.798
(1.76%) $93.49
4.26% $ 35.71
@ $23.69
Wydano: 14 vas. 2024 @ 16:41
Zwrot: 50.74%
Poprzedni sygnał: vas. 13 - 16:30
Poprzedni sygnał:
Zwrot: 11.15 %
Live Chart Being Loaded With Signals
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 13 742.00 |
Średni wolumen | 404 033 |
Kapitalizacja rynkowa | 374.71M |
EPS | $0 ( 2024-03-12 ) |
Następna data zysków | ( $-1.090 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.46 |
ATR14 | $0.157 (0.44%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-10 | Moran Sean F. | Buy | 1 787 | Common Stock |
2024-04-10 | Moran Sean F. | Sell | 1 787 | Employee Stock Option (right to buy) |
2024-03-08 | Cormorant Asset Management, Lp | Buy | 8 862 | Common Stock |
2024-03-08 | Cormorant Asset Management, Lp | Buy | 156 597 | Common Stock |
2024-03-08 | Cormorant Asset Management, Lp | Buy | 61 668 | Common Stock |
INSIDER POWER |
---|
99.57 |
Last 95 transactions |
Buy: 14 080 389 | Sell: 365 661 |
Wolumen Korelacja
Corbus Pharmaceuticals Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
VKTX | 0.923 |
BLPH | 0.919 |
CHMA | 0.904 |
BTF | 0.903 |
ALBO | 0.902 |
SUMO | 0.901 |
CMPI | 0.901 |
NVCN | 0.899 |
IMRX | 0.885 |
NLTX | 0.885 |
10 Najbardziej negatywne korelacje | |
---|---|
MSBI | -0.949 |
BWFG | -0.948 |
NFBK | -0.946 |
CNOB | -0.944 |
ONB | -0.944 |
PFBC | -0.944 |
FBIZ | -0.943 |
PGC | -0.943 |
BCBP | -0.941 |
WSFS | -0.941 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Corbus Pharmaceuticals Korelacja - Waluta/Towar
Corbus Pharmaceuticals Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-641 000 (0.00 %) |
EPS: | $-10.31 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-641 000 (0.00 %) |
EPS: | $-10.31 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-1.49M (0.00 %) |
EPS: | $-13.39 |
FY | 2021 |
Przychody: | $881 705 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.370 |
Financial Reports:
No articles found.
Corbus Pharmaceuticals
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the activation of transforming growth factor ß (TGFß); and CRB-602, an anti-avß6/avß8 mAb that blocks the activation of TGFß for the treatment of fibrotic diseases. The company is also developing cannabinoid receptor type 1 inverse agonist program for the treatment of metabolic disorders, such as obesity, diabetic nephropathy, diabetic retinopathy, and nonalcoholic steatohepatitis; fibrotic diseases, including lung, cardiac, renal disease, and liver fibrosis; and other diseases comprising ascites, cognitive defects, Prader-Willi syndrome, and smoking cessation. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej